| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-07 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |